Artigo Revisado por pares

Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort Studies

2019; Lippincott Williams & Wilkins; Volume: 202; Issue: 3 Linguagem: Inglês

10.1097/ju.0000000000000279

ISSN

1527-3792

Autores

Mohammad Abufaraj, Fred K. Tabung, Shahrokh F. Shariat, Marco Moschini, Elizabeth E. Devore, Kyriaki Papantoniou, Lin Yang, Susanne Strohmaier, Florian Rohrer, Sarah C. Markt, Xuehong Zhang, Edward L. Giovannucci, Eva Schernhammer,

Tópico(s)

Cancer Risks and Factors

Resumo

No AccessJournal of UrologyAdult Urology1 Sep 2019Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort Studies Mohammad Abufaraj, Fred K. Tabung, Shahrokh F. Shariat, Marco Moschini, Elizabeth Devore, Kyriaki Papantoniou, Lin Yang, Susanne Strohmaier, Florian Rohrer, Sarah Coseo Markt, Xuehong Zhang, Edward Giovannucci, and Eva Schernhammer Mohammad AbufarajMohammad Abufaraj Departments of Urology, Medical University of Vienna, Vienna, Austria Division of Urology, Department of Special Surgery, Jordan University Hospital, University of Jordan, Amman, Jordan , Fred K. TabungFred K. Tabung Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts , Shahrokh F. ShariatShahrokh F. Shariat Departments of Urology, Medical University of Vienna, Vienna, Austria Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria Departments of Urology, University of Texas Southwestern Medical Center, Dallas, Texas Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York , Marco MoschiniMarco Moschini Departments of Urology, Medical University of Vienna, Vienna, Austria Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy , Elizabeth DevoreElizabeth Devore Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts , Kyriaki PapantoniouKyriaki Papantoniou Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria , Lin YangLin Yang Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria , Susanne StrohmaierSusanne Strohmaier Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts , Florian RohrerFlorian Rohrer Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria , Sarah Coseo MarktSarah Coseo Markt Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts , Xuehong ZhangXuehong Zhang Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts , Edward GiovannucciEdward Giovannucci Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts , and Eva SchernhammerEva Schernhammer ‡Correspondence: Kinderspitalgasse 15, 1090Vienna, Austria telephone: +43 1 40160 34704; E-mail Address: [email protected] Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts View All Author Informationhttps://doi.org/10.1097/JU.0000000000000279AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Inflammatory reaction has been linked to bladder cancer. Diet, which drives systemic inflammation, may be considered a modifiable risk factor for bladder cancer. We examined the association of diet with pro-inflammatory potential and bladder cancer risk using the novel EDIP (empirical dietary inflammatory pattern) score comprising predefined food groups determining a pattern most predictive of plasma inflammatory markers. Materials and Methods: We followed a total of 172,802 women in the NHS (Nurses' Health Study) from 1984 to 2012 and the NHS II from 1991 to 2013 as well as 45,272 men in the HPFS (Health Professionals Follow-Up Study) from 1986 to 2012. Multivariable adjusted Cox regression models were used to estimate the RR and 95% CI of bladder cancer across EDIP score quintiles. We performed inverse variance weighted meta-analysis to pool estimates across cohorts stratified by smoking status. Results: During 4,872,188 person-years of observation 1,042 incident bladder cancer cases were identified. Overall, high EDIP scores reflecting dietary patterns with pro-inflammatory potential were not associated with a higher risk of bladder cancer (quintile 5 vs 1 pooled multivariable adjusted RR 0.92, 95% CI 0.75–1.12, ptrend = 0.67). Results were consistent across individual cohorts (quintile 5 vs 1 in the NHS RR 1.04, 95% CI 0.78–1.37, ptrend = 0.71; in the NHS II RR 1.44, 95% CI 0.53–3.91, ptrend = 0.13; and in the HPFS RR 0.74, 95% CI 0.55–1.01, ptrend = 0.11). Results were similar regardless of smoking status. Conclusions: We observed no association between diets with pro-inflammatory potential and bladder cancer risk. Although additional studies are needed to explore other nutritional pathways with the potential for bladder cancer prevention, our results suggest that diets associated with inflammation are not associated with bladder cancer risk. References 1. : Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7. Google Scholar 2. : Economic aspects of bladder cancer: what are the benefits and costs?World J Urol 2009; 27: 295. Google Scholar 3. : Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63: 234. Google Scholar 4. : Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States). Cancer Causes Control 2005; 16: 1135. Google Scholar 5. : Meat intake and bladder cancer risk in 2 prospective cohort studies. Am J Clin Nutr 2006; 84: 1177. Google Scholar 6. : Fluid intake and risk of bladder cancer in the Nurses' Health Studies. Int J Cancer 2014; 135: 1229. Google Scholar 7. : Dietary patterns: from nutritional epidemiologic analysis to national guidelines. Am J Clin Nutr 2015; 101: 899. Google Scholar 8. : Development and validation of an empirical dietary inflammatory index. J Nutr 2016; 146: 1560. Google Scholar 9. : An empirical dietary inflammatory pattern score is associated with circulating inflammatory biomarkers in a multi-ethnic population of postmenopausal women in the United States. J Nutr 2018; 148: 771. Google Scholar 10. : An empirical dietary inflammatory pattern score enhances prediction of circulating inflammatory biomarkers in adults. J Nutr 2017; 147: 1567. Google Scholar 11. : Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 2006; 15: 381. Google Scholar 12. : Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score. BJU Int 2011; 108: 1800. Google Scholar 13. : C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int 2008; 101: 978. Google Scholar 14. : Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol 2005; 23: 5746. Google Scholar 15. : Effects of diet on urinary bladder carcinogenesis and cancer prevention. J Nutr 1997; 127: 826S. Google Scholar 16. : Genital and urinary tract diseases and bladder cancer. Cancer Res 1991; 51: 629. Google Scholar 17. : Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 2015; 112: 594. Google Scholar 18. : Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51. Google Scholar 19. : Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol 2017; 185: 570. Google Scholar 20. : Association of dietary inflammatory potential with colorectal cancer risk in men and women. JAMA Oncol 2018; 4: 366. Google Scholar 21. : Test of the national death index. Am J Epidemiol 1984; 119: 837. Google Scholar 22. : Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993; 93: 790. Google Scholar 23. : The inflammatory potential of diet and ovarian cancer risk: results from two prospective cohort studies. Br J Cancer 2017; 117: 907. Google Scholar 24. : Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S. Google Scholar 25. : Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer 2007; 120: 140. Google Scholar 26. : Confidence intervals for heterogeneity measures in meta-analysis. Am J Epidemiol 2013; 178: 993. Google Scholar 27. : Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder. Cancer 2007; 110: 764. Google Scholar 28. : Dietary inflammatory index and risk of bladder cancer in a large Italian case-control study. Urology 2017; 100: 84. Google Scholar 29. : Association between selected dietary scores and the risk of urothelial cell carcinoma: a prospective cohort study. Int J Cancer 2016; 139: 1251. Google Scholar 30. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, D. C.: World Cancer Research Fund/American Institute for Cancer Research 2007. Available at http://www.aicr.org/assets/docs/pdf/reports/Second_Expert_Report.pdf. Accessed March 22, 2019. Google Scholar The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number. Supported by NCI (National Cancer Institute) Grants K99CA207736 (ED), and K99CA207736 (FKT) and U01 CA167552 (W. Willett, HPFS [Health Professionals Follow-Up Study]), CDC (Centers for Disease Control and Prevention)/NIOSH (National Institute for Occupational Safety and Health) Grant R01OH009803 (ES), NHLBI (National Heart Lung and Blood Institute) Grant R01HL034594 (JM), NIH (National Institutes of Health) Grants UM1CA186107 (M. Stampfer), UM1CA176726 (W. Willett) and P01 CA87969 (Nurses' Health Study and Nurses' Health Study II cohorts), and EUSP (European Urological Scholarship Program Grant)/Scholarship S-01-2018 (MA). The authors alone are responsible for the content and writing of the paper. No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article. © 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 202Issue 3September 2019Page: 484-489Supplementary Materials Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.Keywordsfeeding behaviorurinary bladder neoplasmscohort studiesinflammationrisk assessmentMetricsAuthor Information Mohammad Abufaraj Departments of Urology, Medical University of Vienna, Vienna, Austria Division of Urology, Department of Special Surgery, Jordan University Hospital, University of Jordan, Amman, Jordan More articles by this author Fred K. Tabung Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts More articles by this author Shahrokh F. Shariat Departments of Urology, Medical University of Vienna, Vienna, Austria Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria Departments of Urology, University of Texas Southwestern Medical Center, Dallas, Texas Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York Financial interest and/or other relationship with Astellas, Astra Zeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Janssen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Richard Wolfe Roche, Sanochemia, Sanofi, Takeda, Urogen, Movember Foundation and Department of Urology, Medical University of Vienna. More articles by this author Marco Moschini Departments of Urology, Medical University of Vienna, Vienna, Austria Urological Research Institute, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy More articles by this author Elizabeth Devore Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts Financial interest and/or other relationship with Epi Excellence and Bohn Epidemiology. More articles by this author Kyriaki Papantoniou Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria More articles by this author Lin Yang Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria More articles by this author Susanne Strohmaier Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts More articles by this author Florian Rohrer Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria More articles by this author Sarah Coseo Markt Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts More articles by this author Xuehong Zhang Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts More articles by this author Edward Giovannucci Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts More articles by this author Eva Schernhammer Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts ‡Correspondence: Kinderspitalgasse 15, 1090Vienna, Austria telephone: +43 1 40160 34704; E-mail Address: [email protected] More articles by this author Expand All The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number. Supported by NCI (National Cancer Institute) Grants K99CA207736 (ED), and K99CA207736 (FKT) and U01 CA167552 (W. Willett, HPFS [Health Professionals Follow-Up Study]), CDC (Centers for Disease Control and Prevention)/NIOSH (National Institute for Occupational Safety and Health) Grant R01OH009803 (ES), NHLBI (National Heart Lung and Blood Institute) Grant R01HL034594 (JM), NIH (National Institutes of Health) Grants UM1CA186107 (M. Stampfer), UM1CA176726 (W. Willett) and P01 CA87969 (Nurses' Health Study and Nurses' Health Study II cohorts), and EUSP (European Urological Scholarship Program Grant)/Scholarship S-01-2018 (MA). The authors alone are responsible for the content and writing of the paper. No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article. Advertisement PDF downloadLoading ...

Referência(s)
Altmetric
PlumX